Inovio Pharmaceuticals
INO
#9628
Rank
C$0.17 B
Marketcap
C$1.66
Share price
-0.85%
Change (1 day)
-51.08%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -C$0.12 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.13 Billion, an increase over its 2024 earnings that were of -C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.12 Billion-9.73%
2025 -C$0.13 Billion-16.07%
2024 -C$0.16 Billion-20.03%
2023 -C$0.2 Billion-51.56%
2022 -C$0.4 Billion-8.26%
2021 -C$0.43 Billion95.4%
2020 -C$0.22 Billion36.62%
2019 -C$0.17 Billion20.19%
2018 -C$0.14 Billion10.94%
2017 -C$0.13 Billion9.59%
2016 -C$0.11 Billion118.9%
2015 -C$50.1 Million-10.67%
2014 -C$56.08 Million83.32%
2013 -C$30.59 Million
2011 -C$31.56 Million15.64%
2010 -C$27.29 Million37.7%
2009 -C$19.82 Million2.19%
2008 -C$19.4 Million-14.09%
2007 -C$22.58 Million19.12%
2006 -C$18.95 Million9.62%
2005 -C$17.29 Million5.77%
2004 -C$16.35 Million73.08%
2003 -C$9.45 Million12.75%
2002 -C$8.38 Million
2000 -C$12.68 Million53.93%
1999 -C$8.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$37.20 B-31,942.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.03 B-18,958.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.80 B-8,491.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.78 Billion 2,275.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.91 B-9,443.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$11.20 B-9,685.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-C$3.91 Million-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-C$0.23 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA